1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with copper phthalocyanine in 1 studies
Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (copper phthalocyanine) | Trials (copper phthalocyanine) | Recent Studies (post-2010) (copper phthalocyanine) |
---|---|---|---|---|---|
9,156 | 187 | 552 | 320 | 0 | 54 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baluk, P; Gómez, AD; Hashizume, H; Kwan, ML; McDonald, DM | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and copper phthalocyanine
Article | Year |
---|---|
Airway vasculature after mycoplasma infection: chronic leakiness and selective hypersensitivity to substance P.
Topics: Albuterol; Animals; Bronchodilator Agents; Capillary Permeability; Chronic Disease; Dose-Response Relationship, Drug; Drug Hypersensitivity; Evans Blue; Extravasation of Diagnostic and Therapeutic Materials; Indoles; Male; Mycoplasma Infections; Organ Size; Organometallic Compounds; Platelet Activating Factor; Rats; Rats, Inbred F344; Rats, Wistar; Salmeterol Xinafoate; Serotonin; Species Specificity; Specific Pathogen-Free Organisms; Substance P; Trachea | 2001 |